Impact Therapeutics files Senaparib for EU final marketing authorization
Impact Therapeutics says Senaparib has been submitted to the European Commission for a final marketing authorization decision.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.